The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea

Archives of Internal Medicine

Volumn 162, Issue 19, 2002, Pages 2177-2184

  Hurley, Brian W ^a   Nguyen, Cuong C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORPROPAMIDE; CLINDAMYCIN; ERYTHROMYCIN; GOLD DERIVATIVE; IMMUNOGLOBULIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN; VEROTOXIN;

ADULT; ANIMAL MODEL; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COLON RESECTION; DIAGNOSTIC TEST; DIARRHEA; DISEASE PREDISPOSITION; ENZYME IMMUNOASSAY; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; VACCINATION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; RECURRENCE;

EID: 0037190698     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.19.2177     Document Type: Review

References (32)

1. Bartlett JG. Pseudomembranous enterocolitis and antibiotic-associated colitis. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 6th ed. Vol 2. Philadelphia, Pa: WB Saunders Co; 1998: 1633-1647.
2. Finney JM, Gastro-enterostomy for cicatrizing ulcer of the pylorus. Bull Johns Hopkins Hosp. 1893; 4:53.
3. Penner A, Bernheim A. Acute postoperative enterocolitis: Study on pathologic nature of shock. Arch Pathol. 1939;27:966-983.
4. LaHatte LJ, Tedesco FJ, Schuman BM. Antibiotic-associated injury to the gut. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus Gastroenterology. 5th ed. Vol 2. Philadelphia, Pa: WB Saunders Co; 1995:1657-1671.
5. Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis: A prospective study. Ann Intern Med. 1974;81:429-433.
6. LaMont JT, Kelly CP. Bacterial infections of the colon. In: Yamada T, ed. Textbook of Gastroenterology. 3rd ed. Vol 2. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:1945-1964.
7. Hafitz S. Clostridium difficile and Its Toxins [PhD dissertation]. Leeds, England: University of Leeds; 1974.
8. Kelly CP, LaMont JT. Clostridium difficile infection. Ann Rev Med. 1998;49:375-390.
9. Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Ctostridium difficile-associated diarrhea. Clin Infect Dis. 1995;20(suppl 2): S263-S265.
10. Linevsky JK, Kelly CP. Clostridium difficile colitis. In: LaMont JT, ed. Gastrointestinal Infections: Diagnosis and Management. New York, NY: Marcel Dekker; 1997:293-325.
11. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis. 1998;26:1027-1034.
12. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding ON. Acquisition of Clostridium difficile by hospitalized patients: Evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166:561-567.
13. Kelly CP, Pothoulakis C, Vavva F, et al. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C difficile toxins. Antimicrob Agents Chemother. 1996;40:373-379.
14. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet, 1990; 336:97-100.
15. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet, 1998;351:6330-636.
16. Kelly CP, LaMont JT. Treatment of Clostridium difficile diarrhea and colitis. In: Wolfe MM, ed. Gastrointestinal Pharmacotherapy. Philadelphia, Pa: WB Saunders Co; 1993;199-212.
17. Brar HS, Surawicz CM. Pseudomembranous colitis: An update. Can J Gastroenterol. 2000;14:51-56.
18. Alonso R, Munoz C, Gros S, Garcia de Viedma D, Pelaez T, Bouza E. Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J Hosp Infect. 1999;41:145-149.
19. Kelly CP, LaMont JT. Treatmentof Clostridium difficile diarrhea and colitis. In: Wolfe MM, ed. Therapy of Digestive Disorders. Philadelphia, Pa: WB Saunders Co; 2000:519-520.
20. Wilcox MH. Treatment of Clostridium difficile infection. J Antimicrob Chemother. 1998;41(suppl C):41-46.
21. Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol. 1996; 8:1048-1053.
22. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390-397.
23. Tacket CO, Losonsky G, Link H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med. 1988;318:1240-1243.
24. Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS. 1990;4:581-584.
25. Chetham ST, Keates S, Pothoulakis C, et al. C difficile toxin neutralizing activity in hu man feces after oral anti-C difficile bovine immunoglobulin concentrate [abstract]. Gastroenterology. 1996;110 (suppl):A882.
26. Libby JM, Jortner BS, Wilkins TD. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun. 1982;36:822-829.
27. Fernie DS, Thomson RO, Batty I, Walker PD. Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand. 1983;53:325-332.
28. Kim PH, Iaconis JP, Rolfe RD. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun. 1987;55:2984-2992.
29. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh: Results from three-year follow-up. Lancet. 1990;335:270-273.
30. Torres JF, Lyerly DM, Hill JE, Monath TP. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun. 1995;63:4619-4627.
31. Lyerly DM, Bostwick EF, Binion SB, Wilkins TD. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun. 1991;59:2215-2218.
32. Fekety R, for the American College of Gastroenterology, Practice Parameters Committee. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol. 1997;92:739-750.